Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Feb 15, 2013, Zacks Investment Research upgraded Skechers U.S.A., Inc. ( SKX - Analyst Report ) to a Zacks Rank #1 (Strong Buy).
Why the Upgrade?
Skechers has been witnessing rising earnings estimates on the back of better-than-expected fourth-quarter 2012 results reported on Feb 13, 2013. The quarterly earnings came in at 8 cents a share that fared significantly better than a loss of 54 cents delivered in the prior-year quarter and the Zacks Consensus Estimate of a loss of 11 cents on the back of growth witnessed across domestic wholesale, international, and company-operated retail businesses.
Including the recent concluded quarter, this designer, developer and distributor of footwear and apparel has delivered positive earnings surprises in 5 of the last 7 quarters with an average beat of 110.8%.
Skechers is now showing signs of stability as evident from its fourth quarter results. With more emphasis on a new line of products, increased backlog, cost containment efforts, inventory management and margin improvement, the company anticipates sustaining growth momentum in 2013. We believe Skechers, through its distribution networks, subsidiaries and joint ventures is poised to enhance its global reach in the footwear market.
Following the sturdy results, the Zacks Consensus Estimates for 2013 and 2014 increased by 14.1% and 8.1% to 97 cents and $1.34, respectively, in the last 30 days.
Other Stocks to Consider
The stock worth considering in the apparel industry is Michael Kors Holdings Limited ( KORS - Snapshot Report ) , which holds a Zacks Rank #1 (Strong Buy). Other stocks that should be merited include Guess' Inc. ( GES - Analyst Report ) and Adidas AG ( ADDYY ) , both of which carry a Zacks Rank #2 (Buy).
Read the full Analyst Report on SKX
Read the full Analyst Report on GES
Read the full on ADDYY
Read the full Snapshot Report on KORS